This project, initiated by the United States Agency for International Development and World Learning, aimed to provide scientific support practice-oriented training for the members of the newly established Essential Medicine List (EML) Committee and Secretariat in Ukraine. The 3×1-week programme included: Scientific support on Health Technology Assessment (HTA) implementation, EML financing mechanism, and the adaptation of decision-making strategy on procurement and reimbursement of medicines included in the EML. Specific tasks included on-the-job training of HTA, development of a draft strategy on Multi-Criteria Decision Analysis (MCDA) for decision-making and discussions with key representatives of the Ministry of Health, Ministry of Economic Development and Ministry of Finance of Ukraine. 

SRI was the sole scientific partner involved in the project.